228 related articles for article (PubMed ID: 30683472)
1. Genomic insult oriented mitochondrial instability and proliferative hindrance in the bone marrow of aplastic mice including stem/progenitor population.
Chatterjee R; Law S
Pathol Res Pract; 2019 Apr; 215(4):784-793. PubMed ID: 30683472
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic and microenvironmental alterations in bone marrow associated with ROS in experimental aplastic anemia.
Chatterjee R; Law S
Eur J Cell Biol; 2018 Jan; 97(1):32-43. PubMed ID: 29173808
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of vital mitotic kinase-phosphatase signaling in hematopoietic stem/progenitor compartment leads to cellular catastrophe in experimental aplastic anemia.
Chatterjee R; Chattopadhyay S; Law S
Mol Cell Biochem; 2016 Nov; 422(1-2):121-134. PubMed ID: 27632389
[TBL] [Abstract][Full Text] [Related]
4. Kinetic impairment of haemopoietic stem cells in experimentally induced leukemia and aplastic anemia: an inverse correlation.
Chatterjee S; Basak P; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2009; 4(3):179-89. PubMed ID: 20232602
[TBL] [Abstract][Full Text] [Related]
5. Alteration of classical and hematopoiesis specific p53 pathway in the bone marrow hematopoietic stem/progenitor compartment facilitates leukemia progression in experimental mice.
Chatterjee R; Chattopadhyay S; Law S
Leuk Res; 2016 Aug; 47():70-7. PubMed ID: 27280487
[TBL] [Abstract][Full Text] [Related]
6. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
7. Noncanonical Wnt5a-Ca(2+) -NFAT signaling axis in pesticide induced bone marrow aplasia mouse model: A study to explore the novel mechanism of pesticide toxicity.
Chattopadhyay S; Chatterjee R; Law S
Environ Toxicol; 2016 Oct; 31(10):1163-75. PubMed ID: 25846497
[TBL] [Abstract][Full Text] [Related]
8. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.
Bär C; Povedano JM; Serrano R; Benitez-Buelga C; Popkes M; Formentini I; Bobadilla M; Bosch F; Blasco MA
Blood; 2016 Apr; 127(14):1770-9. PubMed ID: 26903545
[TBL] [Abstract][Full Text] [Related]
9. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors.
Găman A; Găman G; Bold A
Rom J Morphol Embryol; 2009; 50(4):669-74. PubMed ID: 19942964
[TBL] [Abstract][Full Text] [Related]
10. Insensitive to PTH of CD8
Li S; Qin M; Wu R; Meng H; He Y; Wang B; Zhou X; Zhu G
Int J Med Sci; 2020; 17(12):1665-1672. PubMed ID: 32714069
[TBL] [Abstract][Full Text] [Related]
11. Hematopathological alterations of major tumor suppressor cascade, vital cell cycle inhibitors and hematopoietic niche components in experimental myelodysplasia.
Chatterjee R; Gupta S; Law S
Chem Biol Interact; 2017 Aug; 273():1-10. PubMed ID: 28549617
[TBL] [Abstract][Full Text] [Related]
12. [A novel rat aplastic anemia model induced by 5-fluorouracil combined with busulfan].
Zhao J; Chu J; Ding S; Xu S; Liu A; Wang S
Zhonghua Xue Ye Xue Za Zhi; 2001 Apr; 22(4):202-4. PubMed ID: 11877074
[TBL] [Abstract][Full Text] [Related]
13. Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions.
Martín-Pardillos A; Tsaalbi-Shtylik A; Chen S; Lazare S; van Os RP; Dethmers-Ausema A; Fakouri NB; Bosshard M; Aprigliano R; van Loon B; Salvatori DCF; Hashimoto K; Dingemanse-van der Spek C; Moriya M; Rasmussen LJ; de Haan G; Raaijmakers MHGP; de Wind N
Blood; 2017 Sep; 130(13):1523-1534. PubMed ID: 28827409
[TBL] [Abstract][Full Text] [Related]
14. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
15. The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice.
Chen YF; Zhao ZQ; Wu ZM; Zou ZY; Luo XJ; Li J; Xie C; Liang Y
Int J Clin Exp Pathol; 2014; 7(12):8411-20. PubMed ID: 25674205
[TBL] [Abstract][Full Text] [Related]
16. Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs.
Jia W; Zhen M; Li L; Zhou C; Sun Z; Liu S; Zhao Z; Li J; Wang C; Bai C
Theranostics; 2020; 10(15):6886-6897. PubMed ID: 32550910
[TBL] [Abstract][Full Text] [Related]
17. [Activation of auto-mesenchymal stem cells of skeletal muscle by bone morphogenetic protein for rescuing bone marrow failure].
Chu JX; Zhao JM; Ding SL; Xu SC; Liu AR; Wang SP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):272-5. PubMed ID: 12905633
[TBL] [Abstract][Full Text] [Related]
18. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.
Wodnar-Filipowicz A; Lyman SD; Gratwohl A; Tichelli A; Speck B; Nissen C
Blood; 1996 Dec; 88(12):4493-9. PubMed ID: 8977241
[TBL] [Abstract][Full Text] [Related]
19. An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan.
Morley A; Blake J
Blood; 1974 Jul; 44(1):49-56. PubMed ID: 4834516
[No Abstract] [Full Text] [Related]
20. Aplastic anemia, cellular and molecular aspects.
Javan MR; Saki N; Moghimian-Boroujeni B
Cell Biol Int; 2021 Dec; 45(12):2395-2402. PubMed ID: 34405925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
